Packer noted that gastrointestinal reports, such as diarrhea, nausea, or constipation, led 4% discontinuation in the tirzepatide arm
The analyses of a trial called Select, whose results showed last year that Wegovy significantly reduced heart risk in addition to helping with weight loss also suggest that the drug may protect the heart in ways beyond weight loss alone, researchers said, raising new questions about how the wildly popular medicines in this drug class should be used and covered by insurers
Register for an account or log in to your account by visiting the link below
You should arrange a consultation if: You're currently using oral contraceptive pills and planning to start or have recently started weight loss injections You're experiencing significant nausea, vomiting, or diarrhoea that might affect medication absorption You're concerned about contraceptive reliability during weight loss treatment You've had unprotected intercourse and are uncertain about your contraceptive protection You're considering pregnancy in the near future, as weight loss medications should be discontinued before conception Your periods become irregular or you experience potential pregnancy symptoms If planning pregnancy , follow medication-specific guidance: Semaglutide (Wegovy): Stop at least 2 months before planned conception Liraglutide (Saxenda): Discontinue before conception (check product information) Tirzepatide: Follow product information (typically at least 1 month before planned conception) Seek urgent medical advice if you suspect you might be pregnant whilst using weight loss injections
Whether you choose injectable BPC-157 or BPC-157 capsules, the goal is to get the compound to the target tissue be it a torn tendon or an inflamed gut lining
